BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 23350491)

  • 1. [Experimental basic research on mammary cancer gene therapy for metastasis inhibition].
    Shibata MA
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():710-4. PubMed ID: 23350491
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model.
    Shibata MA; Morimoto J; Shibata E; Otsuki Y
    Cancer Gene Ther; 2008 Dec; 15(12):776-86. PubMed ID: 18654613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival.
    Chen Z; Varney ML; Backora MW; Cowan K; Solheim JC; Talmadge JE; Singh RK
    Cancer Res; 2005 Oct; 65(19):9004-11. PubMed ID: 16204074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrogene therapy using endostatin, with or without suicide gene therapy, suppresses murine mammary tumor growth and metastasis.
    Shibata MA; Morimoto J; Doi H; Morishima S; Naka M; Otsuki Y
    Cancer Gene Ther; 2007 Mar; 14(3):268-78. PubMed ID: 17096028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.
    Croci S; Nicoletti G; Landuzzi L; Palladini A; Chiarini F; Nanni P; Lollini PL; De Giovanni C
    Oncol Rep; 2007 Aug; 18(2):451-6. PubMed ID: 17611670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.
    Sauter BV; Martinet O; Zhang WJ; Mandeli J; Woo SL
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4802-7. PubMed ID: 10758166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
    Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
    Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
    Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
    Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice.
    Calvo A; Feldman AL; Libutti SK; Green JE
    Cancer Res; 2002 Jul; 62(14):3934-8. PubMed ID: 12124322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of antibody against vascular endothelial growth factor (VEGF) on tumor metastasis].
    Wang G; Yang Z; Shou C
    Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):407-9. PubMed ID: 10920868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental gene therapy in mammary and urinary bladder cancer using electrogene transfer.
    Shibata MA; Morimoto J; Ito Y; Kusakabe K; Otsuki Y
    Med Electron Microsc; 2004 Dec; 37(4):216-24. PubMed ID: 15614446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells.
    Ou-Yang F; Lan KL; Chen CT; Liu JC; Weng CL; Chou CK; Xie X; Hung JY; Wei Y; Hortobagyi GN; Hung MC
    Cancer Res; 2006 Jan; 66(1):378-84. PubMed ID: 16397252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological effects of vascular endothelial growth factor receptor-2-blocking antibody plus fractionated radiotherapy on murine mammary tumors.
    Fenton BM; Paoni SF; Ding I
    Cancer Res; 2004 Aug; 64(16):5712-9. PubMed ID: 15313911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice.
    Li J; Dong X; Xu Z; Jiang X; Jiang H; Krissansen GW; Sun X
    J Biomed Sci; 2008 Jan; 15(1):99-109. PubMed ID: 17705027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mts1 protein and control of tumor metastasis].
    Georgiev GP; Lukanidin EM
    Mol Biol (Mosk); 2000; 34(5):727-30. PubMed ID: 11033794
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.
    Schmitz V; Vilanueva H; Raskopf E; Hilbert T; Barajas M; Dzienisowicz C; Gorschlüter M; Strehl J; Rabe C; Sauerbruch T; Prieto J; Caselmann WH; Qian C
    Gene Ther; 2006 Aug; 13(16):1198-205. PubMed ID: 16617302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
    Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
    Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.